Lynx Business Park
Unit 1B Fordham Road
Snailwell CB8 7NY
United Kingdom
44 16 3872 1500
https://tristel.com
Sektor(en): Healthcare
Branche: Medical Instruments & Supplies
Vollzeitmitarbeiter: 194
Name | Titel | Zahlen | Ausgeübt | Geburtsjahr |
---|---|---|---|---|
Mr. Paul C. Swinney | CEO & Exec. Director | 382,7k | N/A | 1959 |
Ms. Elizabeth A. Dixon | CFO & Exec. Director | 277,42k | N/A | 1970 |
Mr. Bart Victor Margaretha Leemans | Exec. Director | 256,37k | N/A | 1964 |
Ms. Heidi A. Allard | UK Fin. Director, Global Financial Controller & Company Sec. | N/A | N/A | N/A |
Tristel plc develops, manufactures, and sells infection prevention products in the United Kingdom and internationally. The company operates through three segments: Hospital Medical Device Decontamination, Hospital Environmental Surface Disinfection, and Other. It offers medical instrument disinfection products, including airway management, cardiology, ear, nose and throat, endoscopy, ophthalmology, phlebotomy, reproductive health/IVF, surface, ultrasound, urology, women's health, and other products under the Tristel brand; contamination control products, which include cleanroom, laboratory, pharmaceutical, cosmetic, and toiletry disinfectants under the Crystel brand; and airborne and veterinary device disinfectants under the Anistel brand. The company was founded in 1993 and is headquartered in Snailwell, the United Kingdom.
Tristel plcs ISS Governance QualityScore, Stand N/A, lautet N/A. Die grundlegenden Scores sind Audit: N/A, Vorstand: N/A, Shareholderrechte: N/A, Kompensation: N/A.